Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore the top credit cards that provide the most rewards. Maximize your benefits and make the most of your spending.
25,405 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
New projections shift the timeline for potential Social Security cuts earlier, prompting retirees and savers to rethi...
A major alliance between Mastercard and Ripple signals a potential price move for XRP in 2026. This article breaks do...
This analysis dives into worksport (wksp) 2025 earnings, decoding the Q4 2025 transcript. Learn how revenue, margins,...
Geopolitical tensions push fuel costs higher, prompting DoorDash to fund more than $50 million in gas-price relief fo...
A controlled study finds women face harsher judgments when AI helps craft resumes, while men's resumes win quicker ap...
Andreessen Horowitz is tapping California’s pension funds for the first time, led by CalPERS’ $400 million commitment...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
A new Microsoft AI diffusion map shows ordinary Americans across states are adopting AI at surprising rates, not just...